【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biosimilars: Overview
• Comparative analysis of biosimilars and generic small molecules
• Biosimilars market opportunities
• Challenges for new entrants
• Bio-betters
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by application
• Global blood disorders biosimilars market
• Market overview
• Global oncology biosimilars market
• Global chronic and autoimmune diseases biosimilars market
• Global growth hormone deficiency biosimilars market
• Global infectious diseases biosimilars market
• Others
PART 08: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 09: Geographical segmentation
• Global biosimilars market by geographical segmentation 2015-2020
• Biosimilars market in EMEA
• Biosimilars market in APAC
• Biosimilars market in Americas
PART 10: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Reimbursement benefits for biosimilars
• Favorable government regulations
• Promising pipeline
PART 11: Impact of drivers
PART 12: Market challenges
• Physicians reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Risks related to drug failure
• Limited availability of biosimilar products
• Difficulties in patient recruitment for conducting clinical trials
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of biosimilars
• Outsourcing of biosimilar manufacturing activities
• Need for high investment in R&D
• High growth in the emerging markets
• Rising number of strategic collaborations
PART 15: Vendor landscape
• Competitive scenario
• Sandoz
• Hospira
• Teva Pharmaceuticals
• STADA
• Biocon
• Celltrion
• Dr. Reddy’s
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global biosimilar market snapshot
Exhibit 03: Key buying criteria for biosimilars 2015
Exhibit 04: Major timelines in global biosimilars market 2014-2020
Exhibit 05: Impact of key customer segments on market 2015
Exhibit 06: Definition of biosimilars in different regions
Exhibit 07: Comparison between biosimilars and generic small molecules
Exhibit 08: Factors affecting biologics and biosimilars market
Exhibit 09: Impact of biosimilars cost savings on various sectors
Exhibit 10: Factors affecting success of biosimilars
Exhibit 11: Biosimilars industry: Point-of-view
Exhibit 12: Factors influencing uptake of biosimilars
Exhibit 13: Global biosimilars market: Strategic factors for new market entrants
Exhibit 14: Challenges for new entrants
Exhibit 15: Bio-betters and its impact on market
Exhibit 16: Global biosimilars market: Pipeline snapshot 2015
Exhibit 17: Pipeline portfolio: Global biosimilars market 2015
Exhibit 18: Number of approved biosimilars in regulated and semi-regulated markets
Exhibit 19: Patent expirations of major biologics from 2000-2030
Exhibit 20: Global biosimilars market snapshot: Developed and emerging markets 2015
Exhibit 21: Patient assistance programs by vendors
Exhibit 22: Global biosimilars market 2015-2020 ($ billions)
Exhibit 23: Global spending for biosimilars 2015-2020 ($ billions)
Exhibit 24: Global biosimilars market: Key metrics analysis snapshot
Exhibit 25: Current and future trends in global biosimilars market
Exhibit 26: Impact of drivers and challenges on global biosimilars market
Exhibit 27: Five forces analysis
Exhibit 28: Global biosimilars market: Segmentation by application (2015-2020)
Exhibit 29: Applications of biosimilars and its impact on growth of market
Exhibit 30: Global biosimilars market: Segmentation by application 2015
Exhibit 31: Global biosimilars market segmentation: Growth cycle analysis
Exhibit 32: Global blood disorders market biosimilar 2015-2020 ($ billions)
Exhibit 33: Opportunity analysis of global blood disorders biosimilar market by type of application
Exhibit 34: Global oncology biosimilar market 2015-2020 ($ billions)
Exhibit 35: Opportunity analysis of global oncology biosimilar market by type of application
Exhibit 36: Population aged 60 years and over (millions)
Exhibit 37: Global chronic and autoimmune diseases biosimilars market 2015-2020 ($ millions)
Exhibit 38: Opportunity analysis of chronic and autoimmune diseases biosimilars market by application
Exhibit 39: Global growth hormone deficiency biosimilars market 2015-2020 ($ millions)
Exhibit 40: Opportunity analysis of global growth hormone deficiency biosimilars market
Exhibit 41: Global infectious diseases biosimilars market 2015-2020 ($ millions)
Exhibit 42: Opportunity analysis of infectious diseases biosimilars market by application
Exhibit 43: Global biosimilars market segmentation by application 2015
Exhibit 44: Biosimilars market segmentation by end-user 2015
Exhibit 45: Global biosimilars market: Geography outlook (2015-2020)
Exhibit 46: Global biosimilars market: Geography outlook 2015
Exhibit 47: Revenue/growth outlook in different countries/regions 2015
Exhibit 48: Biosimilar market landscape: Country analysis
Exhibit 49: Market penetration of originators and biosimilars in different regions
Exhibit 50: Biosimilars market in EMEA 2015-2020 ($ billions)
Exhibit 51: Biosimilars market in EMEA by region 2015
Exhibit 52: Guidelines for biosimilars in EU
Exhibit 53: Timeline of biosimilars in Europe
Exhibit 54: Geographical segmentation in Europe 2015
Exhibit 55: Patent expirations of major biologics in Europe
Exhibit 56: Key leading countries in EMEA 2015
Exhibit 57: Biosimilars market in Europe 2015-2020 ($ billions)
Exhibit 58: Europe biosimilars market: Opportunity analysis
Exhibit 59: Approved marketed products in Europe
Exhibit 60: Key stake holders in EU biosimilars market
Exhibit 61: PEST analysis: Biosimilars market in Europe 2015
Exhibit 62: Biosimilars market in Germany 2015-2020 ($ millions)
Exhibit 63: Biosimilars market in UK 2015-2020 ($ millions)
Exhibit 64: Biosimilars market in France 2015-2020 ($ millions)
Exhibit 65: Biosimilars market in Italy 2015-2020 ($ millions)
Exhibit 66: Biosimilars market in Spain 2015-2020 ($ millions)
Exhibit 67: Biosimilars market in APAC 2015-2020 ($ billions)
Exhibit 68: Biosimilars market in APAC by country 2015
Exhibit 69: Key leading countries in APAC 2015
Exhibit 70: Biosimilars market in China 2015-2020 ($ millions)
Exhibit 71: China biosimilars market: Opportunity analysis
Exhibit 72: PEST analysis: Biosimilars market in China
Exhibit 73: Timeline for development of biosimilars in India
Exhibit 74: Challenges and strategies in developing biosimilars in India
Exhibit 75: Biosimilars market in India 2015-2020 ($ millions)
Exhibit 76: India biosimilars market: Opportunity analysis
Exhibit 77: Approved biosimilars in India
Exhibit 78: PEST analysis: Biosimilars market in India 2015
Exhibit 79: Review process for biosimilars in Japan
Exhibit 80: Biosimilars approved by PMDA in Japan
Exhibit 81: Biosimilars market in Japan 2015-2020 ($ millions)
Exhibit 82: Biosimilars market in Japan: Opportunity analysis
Exhibit 83: PEST analysis: Biosimilars market in Japan 2015
Exhibit 84: Biosimilars market in Americas 2015-2020 ($ billions)
Exhibit 85: Approvals of biologicals versus biosimilars via public health service act (PHSA)
Exhibit 86: Timeline of biosimilar regulations in US
Exhibit 87: Approval process for biosimilars in US
Exhibit 88: Benefits of biosimilars to US healthcare system
Exhibit 89: Patent expirations of major biologics in US
Exhibit 90: Biosimilars market in US 2015-2020 ($ million)
Exhibit 91: Biosimilars market in US: Opportunity analysis
Exhibit 92: Role of stakeholders in creating awareness in US
Exhibit 93: PEST analysis: Biosimilars market in US 2015
Exhibit 94: Global biosimilars market: Key leading countries (2015)8
Exhibit 95: Patent analysis of biologicals in US
Exhibit 96: Patent analysis of biologicals in Europe
Exhibit 97: Impact of drivers
Exhibit 98: Key reasons as to why physicians are reluctant to prescribe biosimilar6
Exhibit 99: Impact of drivers and challenges
Exhibit 100: Global biosimilars market: Impact assessment of key trends
Exhibit 101: Competitive assessment of vendors
Exhibit 102: Key vendors: Geographical presence 2015
Exhibit 103: Mergers, acquisitions and partnership assessment of major vendors in global biosimilars market
Exhibit 104: Sandoz: YoY revenue and growth rate of biosimilars 2014-2015 ($ millions)
Exhibit 105: Sandoz: Metrics analysis
Exhibit 106: Hospira: Metrics analysis4
Exhibit 107: Teva Pharmaceuticals: Metrics analysis6
Exhibit 108: STADA: Metrics analysis
Exhibit 109: Biocon: Metrics analysis
Exhibit 110: Celltrion: Metrics analysis
Exhibit 111: Dr. Reddy’s: Metrics analysis
【レポート販売概要】
■ タイトル：バイオシミラー（バイオ後続品）の世界市場2016-2020■ 英文：Global Biosimilars Market 2016-2020
■ 発行日：2016年8月1日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10077
■ 調査対象地域：グローバル
- 液体・ガス濾過装置/精製装置市場（～2019）：世界市場The expansion of the global liquid and gas filtering and purifying equipment industry is forecast to reach 4.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.2%. Currently, water filtering and purifying equipment accounts for 12.1% of the global demand while the remaining market share is divided between other beverage filtering and purifyin …
- 疼痛治療薬の世界市場2016-2020About Pain Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a va …
- Noble Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 自動車用スマートフォン対応テレマティクスの世界市場2019-2023109 pages, November 2018 About this market The growing popularity of smartphone enabled telematics in commercial vehicles to gain traction in the market. Automotive smartphone enabled telematics are becoming widely popular in commercial vehicles with fleet operators across the globe. Technavio’s analysts have predicted that the automotive smartphone enabled telematics market will register a CAGR o …
- 医薬品新興国市場：中国、ブラジル、ロシア、インドTechnavios research analyst predicts the pharmerging markets to grow steadily at a CAGR of 13% during the forecast period. The increase in public and private healthcare insurance is the primary growth driver for this market. The governments of various pharmerging countries such as India have implemented several schemes that can be availed by patients to obtain free treatment for different diseases …
- 医薬品包装の世界市場2016-2020Technavios research analyst predicts the global pharmaceutical packaging market to grow at a CAGR of around 6% during the forecast period. The rapid demand for pre-fillable syringes is the primary growth driver for this market. These syringes offer several advantages such as minimization of drug waste, increasing useful product life, and convenience in drug administration and are integrated with a …
- 世界のバイオスティミュラント（バイオ農薬）市場Agricultural biostimulants are natural substances with diverse formulation compounds, which are applied to soil and plants to improve and regulate crops physiological processes for crop enhancement. Biostimulants stimulate plant growth to improve crop yields, vigor, and quality. The global biostimulants market consists of acid based and extracts based biostimulants. Acid based biostimulants are fu …
- スマートグリッド向け電池電力貯蔵システムの世界市場2016-2020About the Battery Energy Storage Market for Smart Grid The suppression or filtering of electromagnetic noise in connectors can be achieved by adding diodes and capacitors to separate interfering high-voltage or high-frequency noise from the desired lower frequency signals. These connectors are called filtered connectors and have been used in the industry for more than three decades to provide cost …
- 世界の自動車用エアバッグ市場動向（2012-2016）TechNavio's analysts forecast the Global Automotive Airbag market to grow at a CAGR of 8.31percent over the period 2012-2016. The rapid growth of the Global Automotive Safety Systems market is one of the key factors contributing to the growth of Global Automotive Airbag market. The Global Automotive Airbag market has also been witnessing the increasing demand for automotive airbags from the BRIC c …
- エンタープライズ・アセット・マネジメント（EAM）ソフトウェアの世界市場Over the past few years, the market for enterprise asset management (EAM) has developed and has adopted the latest software applications due to its increasing demand among organizations across different industries. EAM is a new model that is presently gaining approval in asset centric organizations where repair activities have to be closely synchronized with the additional enterprise extensive fun …
- 2014年戦略提言：アメリカの血液及びフローサイトメトリー市場Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.SummaryThis comprehensive report contains 275 pages, 36 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry markets during the next five years. The report explores business and tech …
- 統合ドライブシステム （IDS）の世界市場予測（～2022）：提供形態別（ハードウェア、ソフトウェア、サービス）、通信プロトコル別、産業別、地域別According to MarketsandMarkets’ forecast, the integrated drive systems market, in terms of value, is expected to grow from USD 23.89 Billion in 2015 to USD 38.27 Billion by 2022, at a CAGR of 6.80% between 2016 and 2022. The major drivers for the market include the advancement and rapid growth in automation, increasing adoption of energy-efficient international standards and integrated drive syste …
- テリアルハンドリング装置の世界市場2016-2020About Material Handling Equipment Material handling equipment refers to a range of products that aid transportation and storage of material. The equipment enhances the operational efficiency and the workflow in manufacturing, streamlines supply chain distribution channel, and manages warehouse operations for optimum utilization. The equipment provides an accurate, process efficient, and cost-effec …
- 世界のマイクロサーバ市場Micro servers are an emerging form factor of servers designed to process low intensive workloads like lightweight web serving; simple content delivery nodes and low end dedicated hosting. They are basically low power servers consisting of several nodes that share a common architecture. Increasing demand for servers in data center due to the explosive growth of data usage among customers and the po …
- マグネシウムの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Magnesium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories P …
